Annals of the ICRP
Volume 33, Issue 4 , Pages 1-121 , December 2003

Relative biological effectiveness (RBE), quality factor (Q), and radiation weighting factor (wR) ICRP Publication 92

  • J. Valentin

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +46-8-729-7275; fax: +46-8-729-7298

References 

  1. Albert R, Omran A, Brauer E, et al.  Follow-up study of patients treated by x-ray epilation for tinea capitis. II. Results of clinical and laboratory examinations. Arch. Environ. Health. 1968;17:919–934
  2. Alpen EL, Powers-Risius P, Curtis SB, et al.  Fluence based relative biological effectiveness for charged particle carcinogenesis in mouse Harderian gland. Adv. Space Res. 1994;14:573–581
  3. Andersson M, Carstensen B, Visfeldt J. Leukaemia and other related hematological disorders among Danish patients exposed to Thorotrast. Radiat. Res. 1993;134:224–233
  4. Bateman JL, Rossi HH, Kellerer AM, et al.  Dose-dependence of fast neutron RBE for lens opacification in mice. Radiat. Res. 1972;51:381–390
  5. Bauchinger M, Schmid E, Streng S, et al.  Quantitative analysis of the chromosome damage at first division of human lymphocytes after 60Co-γ-irradiation. Radiat. Env. Biophys. 1983;22:225–229
  6. Baverstock, K.F., Charlton, D.E. (Eds.) (1988) DNA Damage by Auger Emitters. Report on a Workshop on 17 July 1987. Taylor and Francis, London, UK.
  7. Belkacemi Y, Ozsahin M, Pene F, et al.  Cataractogenesis after total body irradiation. Int. J. Radiat. Oncol. Biol. Phys. 1996;35:53–60
  8. Blakely EA, Kronenberg A. Heavy-ion radiobiology (new approaches to delineate mechanisms underlying enhanced biological effectiveness). Radiat. Res. 1998;150:S126–S145
  9. Boice JD. Leukaemia risk in thorotrast patients. Radiat. Res. 1993;136:301–302
  10. Bond VP, Meinhold CB, Rossi HH. Low-dose RBE and Q for x ray compared to gamma-ray radiations. Health Phys. 1978;34:433–438
  11. Borek C, Hall EJ, Rossi HH. Malignant transformation in cultured hamster embryo cells produced by x rays, 430 keV monoenergetic neutrons and heavy ions. Cancer Res. 1978;38:2997–3005
  12. Borek C, Hall EJ, Zaider M. x rays may be twice as potent as gamma rays for malignant transformation at low doses. Nature. 1983;301:156–158
  13. Bozkurt A, Chao TC, Xu XG. Fluence-to-dose conversion coefficients from monoenergetic neutrons below 20 MeV based on the Vip-Man anatomical model. Phys. Med. Biol. 2000;45:3059–3079
  14. Bozkurt A, Chao TC, Xu XG. Fluence-to-dose conversion coefficients based on the Vip-Man anatomical model and MCNPX code for monoenergetic neutrons above 20 MeV. Health Physics. 2001;81:184–202
  15. Breckon G, Cox R. Alpha particle leukaemogenesis. Lancet. 1990;1:656–657
  16. Brenner DJ, Medvedovsky C, Huang Y, et al.  Accelerated heavy particles and the lens. VIII. Comparisons between the effects of acute low doses of iron ions (190 keV/μm) and argon ions (88 keV/μm). Radiat. Res. 1993;133:198–203
  17. Brenner DJ, Miller RC, Huang Y, et al.  The biological effectiveness of radon-progeny alpha particles. III. Quality factors. Radiat. Res. 1995;143:61–69
  18. Brenner DJ, Sawant SG, Hande MP, et al.  Routine screening mammography (how important is the radiation-risk side of the benefit-risk equation?). Int. J. Radiat. Biol. 2002;78:1065–1067
  19. Broerse JJ, Hennen LA, van Zweiten MJ. Radiation carcinogenesis in experimental animals and its implications for radiation protection. Int. J. Radiat. Biol. 1985;48:167–187
  20. Broerse JJ, van Bekkum DW, Zoetelief J, et al.  Relative biological effectiveness for neutron carcinogenesis in monkeys and rats. Radiat. Res. 1991;128(Suppl.):S128–S135
  21. Brooks AL. Chromosome damage in liver cells from low dose rate alpha, beta and gamma irradiation (derivation of RBE). Science. 1975;190:1090–1092
  22. Burchall PRJ, James AC. Uncertainty analysis of the effective dose per unit exposure from radon progeny and implications for ICRP risk weighting factors. Radiat. Prot. Dosim. 1994;53:133–140
  23. Burns FJ, Albert RE. Dose response for rat skin tumors induced by single and split doses of argon ions. In:  Pirruciello MC,  Tobias CA editor. Biological and Medical Research with Accelerated Heavy Ions at the Bevalac, Berkeley. Berkeley, USA: University of California Press; 1981;p. 223–235
  24. Burns FJ, Hosselet S, Garte SJ. Extrapolations of rat skin tumor incidence: dose, fractionation and linear energy transfer. In:  Baverstock KF,  Stather JW editor. Low Dose Radiation Biological Bases of Risk Assessment. London, UK: Taylor and Francis; 1989;p. 571–584
  25. Burns FJ, Zhao P, Xu G, et al.  Fibroma induction in rat skin following single or multiple doses of 1.0 GeV/nucleon 56Fe ions from the Brookhaven Alternating Gradient Synchrotron (AGS). Phys. Med. 2001;17(Suppl.):194–195
  26. Carnes BA, Grahn D, Thomson JF. Dose–response modelling of the life shortening in a retrospective analysis of the combined data from the JANUS program at Argonne National Laboratory. Radiat. Res. 1989;119:39–56
  27. Chan GL, Little JB. Neoplastic transformation in vitro. In:  Upton AC,  Albert RE,  Burns FE, et al. editor. Radiation Carcinogenesis. Amsterdam, The Netherlands: Elsevier; 1986;p. 108–136
  28. Charlton DE. Calculation of single and double strand DNA breakage from incorporated 125I. In:  Baverstock KF,  Charlton DE editor. DNA Damage by Auger Emitters. London, UK: Taylor and Francis; 1988;p. 89–100
  29. CIRRPC (1995) Committee on Interagency Radiation Research and Policy Coordination. Science Report No. 10. ORAU 95/F-29. Office of Science and Technology Policy, Executive Office of the President, Washington, USA.
  30. Clapp NK, Darden EB, Jernigan MC. Relative effects of whole-body sublethal doses of 60-MeV protons and 300 kVp x rays on disease incidences in 1 RF mice. Radiat. Res. 1974;57:158–186
  31. Covelli V, Coppola M, Di Majo V, et al.  Tumor induction and life shortening in BC3F1 female mice at low doses of fast neutrons and x rays. Radiat. Res. 1989;113:362–374
  32. Cox R, Thacker J, Goodhead DT, et al.  Mutation and inactivation of cultured mammalian cells by various ionizing radiations. Nature. 1977;267:425–427
  33. Cucinotta FA, Manuel FK, Jane J, et al.  Space radiation and cataracts in astronauts. Radiat. Res. 2001;156:460–466
  34. Dalrymple GV, Lindsay IR, Mitchell JC, et al.  Review of the USAF/NASA Proton Bioeffects Project: rationale and acute effects. Radiat. Res. 1991;126:117–119
  35. Di Majo V, Coppola M, Rebessi S, et al.  Age-related susceptibility of mouse liver to induction of tumors by neutrons. Radiat. Res. 1990;124:227–234
  36. Di Majo V, Coppola M, Rebessi S, et al.  The influence of sex on life shortening and tumor incidence in CBA/Cne mice exposed to x rays and fission neutrons. Radiat. Res. 1996;146:181–187
  37. Di Paola M, Coppola M, Baarli T, et al.  Biological responses to various neutron energies from 1 to 600 MeV. A II. Lens opacification in mice. Radiat. Res. 1980;84:453–461
  38. Dietze G, Siebert BRL. Photon and neutron dose contributions and mean quality factors phantoms of different size irradiated by monoenergetic neutrons. Radiat. Res. 1994;140:130–133
  39. Dvorak R, Kliauga P. Microdosimetric measurements of ionization by monoenergetic photons. Radiat. Res. 1978;73:1–20
  40. Edwards AA, Purrott RJ, Prosser JS, et al.  The induction of chromosome aberrations in human lymphocytes by alpha-radiation. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 1980;38:83–91
  41. Edwards, A.A., Lloyd, D.C., Purrott, R.J, et al. (1982) The dependence of chromosome aberration yields on dose rate and radiation quality. In: Research and Development Report, 1979-1981, R&D 4. National Radiological Protection Board, Chilton, Oxon, UK.
  42. Edwards AA, Lloyd DC, Prosser JS. Induction of chromosome aberrations in human lymphocytes by accelerated charged particles. Radiat. Prot. Dosim. 1985;13:205–209
  43. Edwards AA, Lloyd DC, Prosser JS, et al.  Chromosome aberrations induced in human lymphocytes by 8.7 MeV protons and 23.5 helium-3 ions. Int. J. Radiat. Biol. 1986;50:137–145
  44. Edwards AA, Moiseenko V, Nikjoo H. Modelling of DNA breaks and the formation of chromosome aberrations. Int. J. Radiat. Biol. 1994;66:633–637
  45. Edwards AA. The use of chromosomal aberrations in human lymphocytes for biological dosimetry. Radiat. Res. 1997;148(Suppl.):S39–S44
  46. Edwards AA. Neutron RBE values and their relationship to judgements in radiological protection. J. Radiol. Prot. 1999;19:93–105
  47. Edwards AA. RBE of radiations in space and the implications for space travel. Phys. Med. 2001;17(Suppl.):147–152
  48. Engels H, Wambersie A. Relative biological effectiveness of neutrons for cancer induction and other late effects (a review of radiological data). Recent Results Cancer Res. 1998;150:54–87
  49. Evans RD. The effect of skeletally deposited alpha-ray emitters in man. Br. J. Radiol. 1966;468:881–895
  50. Evans RD. Radium poisoning (a review of the present knowledge). Health Phys. 1980;38:899–905
  51. Failla G, Henshaw P. The relative biological effectiveness of x rays and gamma rays. Radiology. 1931;17:1–43
  52. Fedorenko BS, Abrosimova AN, Smirnova OA. The effect of high-energy accelerated particles on the crystalline lens of laboratory animals. Phys. Part. Nucl. 1995;26:573–588
  53. Ford J, Terzaghi M. Effects of 210Pu alpha particles on survival and preoplastic transformation of primary rat tracheal epithelial cells irradiated while in suspension or in intact tissue. Radiat. Res. 1993;136:89–96
  54. Frankenberg D, Kelnhofer K, Bar K, et al.  Enhanced neoplastic transformation by mammography x rays relative to 200 kVp x rays (indication for a strong dependence on photon energy of the RBEM for various end points). Radiat. Res. 2002;157:99–105 Erratum in Radiat. Res. 2002, 158, 126
  55. Fry RJ, Powers-Risius P, Alpen EL, et al.  High-LET radiation carcinogenesis. Radiat. Res. 1985;104(Suppl.):S188–S195
  56. Fry SA. Studies of U.S. radium dial workers: an epidemiological classic. Radiat. Res. 1998;150(Suppl.):S21–S29
  57. Fry RJ. Deterministic effects. Health Phys. 2001;80:338–343
  58. Geard CR. Chromosomal aberration production by track segment charged particles as a function of linear energy transfer. Radiat. Prot. Dosim. 1985;13:199–204
  59. Gerwick LE, Kozin SV. Relative biological effectiveness of proton beams in clinical therapy. Radiother. Oncol. 1999;50:135–142
  60. Gössner W. Pathology of radium-induced bone tumors (new aspects of histopathology and histogenesis). Radiat. Res. 1999;152(Suppl.):S12–S15
  61. Gössner W, Masse R, Stather JW. Cells at risk for dosimetric modelling relevant to bone tumor induction. Radiat. Prot. Dosim. 2000;92:209–213
  62. Gössner, W. (2003) Target cells in internal dosimetry. In: Proceedings: Workshop on Internal Dosimetry of Radionuclides, Oxford, September 2002. Radiat. Prot. Dosim., 105, 39–42.
  63. Grahn D, Lombard LS, Carnes BA. The comparative tumorigenic effects of fission neutrons and cobalt-60 gamma rays in the B6CF1 mouse. Radiat. Res. 1992;129:19–36
  64. Grogan HA, Sinclair WK, Voilleque PG. Risks of fatal cancer from inhalation of 239,240plutonium by humans (a combined four-method approach with uncertainty evaluation). Health Phys. 2001;80:447–461
  65. Gueulette J, Gregoire V, Octave-Prignot M, et al.  Measurements of radiological effectiveness in the 85 MeV proton beam produced at the cyclotron CYCLONE of Louvain-La Neuve, Belgium. Radiat. Res. 1996;145:70–74
  66. Hall EJ, Rossi HH, Zaider M, et al.  The role of neutrons in cell transformation research. II Experimental. In:  Broerse JJ,  Gerber GB editor. Neutron Carcinogenesis. CEC Report Eur 8084. Luxembourg: Commission of the European Communities; 1982;p. 381–396
  67. Han A, Elkind MM. Transformation of mouse C3H 10 T 1/2 cells by single and fractionated doses of x rays and fission neutrons. Cancer Res. 1979;39:123–130
  68. Hill CF, Han A, Elkind MM. Fission-spectrum neutrons at a low dose rate enhance neoplastic transformation in the linear low dose region (0–10 cGy). Int. J. Radiat. Biol. 1984;46:11–15
  69. Hill C, Carnes BA, Han A, et al.  Neoplastic transformation is enhanced by multiple low doses of fission-spectrum neutrons. Radiat. Res. 1985;102:404–410
  70. IARC (2000) World Health Organization, International Agency for Research on Cancer. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol 75. Ionizing Radiation, Part 1: X- and Gamma (γ)-Radiation and Neutrons. IARC, Lyon, France.
  71. IARC (2001) World Health Organization, International Agency for Research on Cancer. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol 78. Ionizing Radiation, Part 2: Some Internally Deposited Radionuclides. IARC, Lyon, France.
  72. ICRP . Recommendations of the International Commission on Radiological Protection and of the International Commission on Radiological Units (NBS 47, 1950). Revised by the International Commission on Radiological Protection at the Sixth International Congress of Radiology, London, UK, 1950. Brit. J. Radiol. 1951;24:46–53
  73. ICRP . Recommendations of the International Commission on Radiological Protection (Revised 1954). Br. J. Radiol. 1955;(Suppl. 6):
  74. ICRP . Recommendations of the International Commission on Radiological Protection. ICRP Publication 26, Ann. ICRP. 1977;1(3):
  75. ICRP . Nonstochastic effects of ionizing radiation. ICRP Publication 41, Ann. ICRP. 1984;14(3):
  76. ICRP . RBE for deterministic effects. ICRP Publication 58, Ann. ICRP. 1990;20(4):
  77. ICRP . Recommendations of the International Commission on Radiological Protection. ICRP Publication 60, Ann. ICRP. 1991;21(1–3):
  78. ICRP . Conversion coefficients for use in radiological protection against external radiation. ICRP Publication 74, Ann. ICRP. 1996;26(3/4):
  79. ICRU . Report 9. Report of the International Commission on Radiological Unit and Measurements. Washington, DC: ICRU; 1959; (NBS 78, 1961)
  80. ICRU, ICRP . Report of the RBE Committee of the International Commissions on Radiological Protection and on Radiological Units. Health Phys. 1963;9:357–384
  81. ICRU . Linear Energy Transfer, ICRU Report 16. Bethesda, Maryland, USA: International Commission on Radiation Units and Measurements; 1970;
  82. ICRU . Radiation Quantities and Units, ICRU Report 33. Bethesda, Maryland, USA: International Commission on Radiation Units and Measurements; 1980;
  83. ICRU . Microdosimetry, ICRU Report 36. Bethesda, Maryland, USA: International Commission on Radiation Units and Measurements; 1983;
  84. ICRU . Determination of Dose Equivalents Resulting from External Radiation Source, ICRU Report 39. Bethesda, Maryland, USA: International Commission on Radiation Units and Measurements; 1985;
  85. ICRU . The Quality Factor in Radiation Protection, ICRU Report 40. Bethesda, Maryland, USA: International Commission on Radiation Units and Measurements; 1986;
  86. ICRU . Stopping Powers and Ranges of Protons and Alpha Particles with Data Disk, ICRU Report 49. Bethesda, Maryland, USA: International Commission on Radiation Units and Measurements; 1993;
  87. ICRU . Quantities and Units in Radiation Protection Dosimetry. Bethesda, MD: International Commission on Radiation Units and Measurements; 1993;
  88. Joiner MC, Lambin P, Malaise EP, et al.  Hypersensitivity to very-low single radiation doses (its relationship to the adaptive response and induced radioresistance). Mutat. Res. 1996;358:171–183
  89. Kassis AI, Fayad F, Kinsey BM, et al.  Radiotoxicity of 125I in mammalian cells. Radiat. Res. 1987;111:305–318
  90. Kellerer AM, Rossi HH. The theory of dual radiation action. Curr. Topics Radiat. Res. Quart. 1972;8:85–158
  91. Kellerer AM, Rossi H. Biophysical aspects of radiation carcinogenesis. In:  Becker FF editors. Cancer. A Comprehensive Treatise, 2nd edn. New York, USA: Plenum Press; 1982;p. 569–616
  92. Kellerer AM, Hahn K. Considerations on a revision of the quality factor. Radiat. Res. 1988;114:480–488
  93. Kellerer AM, Hahn K. The quality factor for neutrons in radiation protection (physical parameters). Radiat. Protect. Dosim. 1988;23:73–78
  94. Kellerer AM, Walsh L. Risk estimation for fast neutrons with regard to solid cancer. Radiat. Res. 2001;156:708–717
  95. Kellerer AM, Walsh L. Solid cancer risk coefficient for fast neutrons in terms of effective dose. Radiat. Res. 2002;158:61–68
  96. Kellerer AM. Electron spectra and the RBE of x rays. Radiat. Res. 2002;158:13–22
  97. Kiefer J, Schmidt P, Koch S. Mutations in mammalian cells induced by heavy charged particles (an indicator for risk assessment in space). Radiat. Res. 2001;156:607–611
  98. Kocher, D.C. (2001) Comments on the radioepidemiological tables, and the supporting interactive computer program (IREP), developed under the EEPICA by NIOSH. http://www.cdc.gov/niosh/ocas/pdfs/.
  99. Kocher, D.C., Apostoaei, A.I., Hoffman, O. (2002) Proposed revision to RBE factors. http://www.cdc.gov/niosh/ocas/pdfs/ireprevf.pdf.
  100. Koshurnikova NA, Gilbert ES, Shilnikova NS, et al.  Studies on the Mayak nuclear workers (health effects). Radiat. Environ. Biophys. 2002;41:29–31
  101. Kraft G. Radiobiological effects of very heavy ions (Inactivation, chromosomal aberration and strand breaks). Nuclear Sci. Application. 1987;3:1–28
  102. Kreisheimer M, Koshurnikova NA, Nekolla E, et al.  Lung cancer mortality among male nuclear workers of the Mayak facilities in the former Soviet Union. Radiat. Res. 2000;154:3–11
  103. Lafuma J, Chemelevsky D, Chameaud J, et al.  Lung carcinomas in Sprague-Dawley rats after exposure to low doses of radon daughters, fission neutrons or γ rays. Radiat. Res. 1989;118:230–245
  104. Land C, Gilbert E, Smith J, et al.  Report of the NCI-CDC Working Group to revise the 1985 NIH radioepidemiological tables (Overview). Health Phys. 2002;82(Suppl.):S187–S188
  105. Lea, D.E. (1946) Actions of Radiations on Living Cells, 1st edn. Macmillan, New York, USA [2nd edn., University Press, Cambridge (1956)].
  106. Leuthold G, Mares V, Schraube H. Calculation of the neutron ambient dose equivalent on the basis of the ICRP revised quality factors. Radiat. Prot. Dosim. 1992;40:77–84
  107. Leuthold, G., Mares, V., Schraube, H. (1997) Monte-Carlo calculations of dose equivalents for neutrons in anthropomorphic phantoms using the ICRP 60 recommendations and the stopping power data of ICRU 49. GSF Report.
  108. Lindborg L. Microdosimetry measurements in beam of high energy photons and electrons: technique and results. In:  Booz J,  Ebert HG,  Smith BGR editor. Proceedings of the 5th Symposium on Microdosimetry, Report No. EUR 5452. Luxembourg: Commission of the European Communities; 1976;
  109. Lloyd EL, Gemmell HA, Henning CB, et al.  Transformation of mammalian cells by alpha particles. Int. J. Radiat. Biol. 1979;36:467–478
  110. Lloyd RD, Miller SC, Taylor GN, et al.  Relative effectiveness of 239Pu and some other internal emitters for bone cancer induction in beagles. Health Phys. 1994;67:346–353
  111. Lundgren DL, Haley PJ, Hahn FHJ, et al.  Pulmonary carcinogenicity of repeated inhalation exposure of rats to aerosols of 239PuO2. Radiat. Res. 1995;142:39–53
  112. Machinami, N., Ishikawa, Y., Boecker, B.B. (Eds.). (1999). The International Workshop on the Health Effects of Thorotrast, Radium, Nadon and other Alpha-Emitters. Radiat. Res. 142, 6 (Suppl.)
  113. Makrigiorgios G, Adelstein SJ, Kassis AI. Auger electron emitters (Insights gained from in vitro experiments). Rad. Environ. Biophysics. 1990;29:75–91
  114. Mares V, Leuthold G, Schraube H. Organ doses and dose equivalents for neutrons above 20 MeV. Radiat. Protect. Dosim. 1997;70:391–394
  115. Martin SG, Miller RC, Geard CR, et al.  The biological effectiveness of radon-progeny alpha particles. IV. Morphological transformation of Syrian hamster embryo cells at low doses. Radiat. Res. 1995;142:70–77
  116. Mays CW, Finkel MP. RBE of α particles vs. β particles in bone sarcoma induction. In: Proceedings of the 5th International Congress of IRPA, Vol. 11. Jerusalem, Israel: Israel Health Physics Society; 1980;p. 41
  117. Mays CW, Spiess H. Bone sarcomas in patients given radium-224. In:  Boice JD,  Fraumeni JF editor. Radiation Carcinogenesis: Epidemiology and Biological Significance. New York, USA: Raven Press; 1984;p. 241–252
  118. Mays CW, Taylor GN, Lloyd RD. Toxicity ratios: their use and abuse in predicting risk from induced cancer. In:  Thompson RC,  Mahaffy JA editor. Life-span Radiation Effects Studies in Animals: What Can They Tell Us? CONF-830951. Proceedings of the 22nd Hanford Life Sciences Symposium, September 1983. Springfield, Virginia, USA: Office of Scientific and Technical Information; 1986;
  119. Merriam GR, Focht EF. A clinical study of radiation cataracts and the relationship to dose. Am. J. Roent. Radium Ther. Nuclear Med. 1957;LXVII:759–785
  120. Merriam GR, Focht EF. A clinical and experimental study of the effect of single and divided doses of radiation on cataract production. Trans. Am. Ophtalmol. Soc. 1962;60:35–52
  121. Miller RC, Hall EJ. Oncogenic transformation of C3H 10T1/2 cells by acute and protracted exposures to monoenergetic neutrons. Radiat. Res. 1991;128(Suppl.):S60–S64
  122. Miller RC, Marino SA, Napoli J, et al.  Oncogenic transformation in C3H10T1/2 cells by low-energy neutrons. Int. J. Radiat. Biol. 2000;76:327–333
  123. Mori T, Kido C, Fukutomi K, et al.  Summary of entire Japanese thorotrast follow-up study (updated 1998). Radiat. Res. 1999;152(Suppl.):S84–S87
  124. Morstin K, Bond VP, Baum JW. Probabilistic approach to obtain hit-size effectiveness functions which relate microdosimetry and radiobiology. Radiat. Res. 1989;120:383–402
  125. Muirhead CR, Cox R, Stather JW, et al.  Relative biological effectiveness (Alpha particles). Documents of the NRPB. 1997;4:129–136
  126. NAS (1999) National Academy of Sciences. Health Effects of Exposure to Radon. BEIR VI. National Academy Press, Washington, USA.
  127. NCRP . Influence of Dose and its Distribution in Time on Dose-Response Relationships for Low-LET Radiations. NCRP Report No. 64. Bethesda, Maryland, USA: National Council on Radiation Protection and Measurements; 1980;
  128. NCRP . The Relative Biological Effectiveness of Radiations of Different Quality. NCRP Report 104. Bethesda, Maryland, USA: National Council on Radiation Protection and Measurements; 1990;
  129. NCRP . Some Aspects of Strontium Radiobiology. NCRP Report 110. Bethesda, Maryland, USA: National Council on Radiation Protection and Measurements; 1991;
  130. NCRP . Limitation of Exposure to Ionizing Radiation. NCRP Report 116. Bethesda, Maryland, USA: National Council on Radiation Protection and Measurements; 1993;
  131. NCRP . Uncertainties in Fatal Cancer Risk Estimates Used in Radiation Protection. NCRP Report No. 126. Bethesda, Maryland, USA: National Council on Radiation Protection and Measurements; 1997;
  132. NCRP . Radiation Protection Guidance for Activities in Low-Earth Orbit. NCRP Report No. 132. Bethesda, Maryland, USA: National Council on Radiation Protection and Measurements; 2000;
  133. Neary GJ, Munson RJ, Mole RH. Chronic Radiation Hazards: An Experimental Study with Fast Neutrons. New York, USA: Pergamon Press; 1957;
  134. Nekolla EA, Kreisheimer M, Kellerer AM, et al.  Induction of malignant bone tumors in radium-224 patients (risk estimates based on the improved dosimetry). Radiat. Res. 2000;153:93–103
  135. Niemer-Tucker MM, Sterk CC, Dewolf-Roundaal D, et al.  Late ophthalomogical complications after total body irradiation in non-human primates. Int. J. Radiat. Biol. 1999;75:465–472
  136. NIH . Publication 85-2748: Report of the NIH Ad Hoc Working Group to Develop Radioepidemiological Tables. Washington, DC: National Institutes of Health, US Department of Health and Human Services; 1985;
  137. NRPB . Relative Biological Effectiveness of Neutrons for Stochastic Effects. Documents of the NRPB 8 (2). Chilton, Didcot, UK: National Radiological Protection Board; 1997;
  138. Obe G, Johannes I, Johannes C, et al.  Chromosomal aberrations in blood lymphocytes of astronauts after long-term space flights. Int. J. Radiat. Biol. 1997;72:727–734
  139. O'Sullivan D. (1999) Study of Radiation Fields and Dosimetry at Aviation Altitudes. Final Report 1996-1999. EU Contract Number F14P-CT950011. http://www.dias.ie/dias/cosmic/general/Publications/1999/TechReport/DIAS-99-9-1/DIAS-99-9-1.pdf.
  140. Otake M, Schull WJ. Radiation-related posterior lenticular opacities in Hiroshima and Nagasaki atomic bomb survivors based on the DS86 dosimetry system. Radiat. Res. 1990;121:3–13
  141. Paganetti H, Olko P, Kobus H, et al.  Calculation of relative biological effectiveness for proton beams using biological weighting functions. Int. J. Radiat. Oncol. Biol. Phys. 1997;37:719–729
  142. Paganetti H, Niemierko A, Ancukiewicz M, et al.  Relative biological effectiveness (RBE) values for proton beam therapy. Int. J. Radiat. Oncol. Biol. Phys. 2002;53:407–421
  143. Pelliccioni W. Radiation weighting factors and high energy radiation. Radiat. Protect. Dosimet. 1998;80:371–378
  144. Pierce DA, Preston DL. Radiation-related cancer risks at low doses among atomic bomb survivors. Radiat. Res. 2000;154:178–186
  145. Preston DL, Mattsson A, Holmberg E, et al.  Radiation effects on breast cancer risk (a pooled analysis of eight cohorts). Radiat. Res. 2002;158:220–235
  146. Preston DL, Shimizu Y, Pierce DA, et al.  Studies of mortality of atomic bomb survivors. Report 13 solid cancer and non-cancer disease mortality: 1950–1977. Radiat. Res. 2003;160:381–407
  147. Purrott RJ, Edwards AA, Lloyd DC, et al.  The induction of chromosome aberrations in human lymphocytes by in vitro irradiation with alpha-particles from plutonium-239. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 1980;38:277–284
  148. Raabe OG, Book SA, Parks NJ. Lifetime bone cancer dose-response relationships in beagles and people from skeletal burden of 226Ra and 90Sr. Health Phys. 1983;14(Suppl.):33–48
  149. Raju MR. Proton radiobiology, radiosurgery and radiotherapy. Int. Radiat. Biol. 1995;67:237–259
  150. Riches AC, Herceg Z, Bryant PE, et al.  Radiation-induced transformation of SV 40-immortalized human thyroid epithelial cells by single exposure to plutonium α particles in vitro. Int. J. Radiat. Biol. 1997;72:515–521
  151. Ritter S, Kraft-Weyrather W, Scholz M, et al.  Induction of chromosome aberrations in mammalian cells after heavy ion exposure. Adv. Space Res. 1992;12:119–125
  152. Rossi HH. Sensible radiation protection. Health Phys. 1995;69:394–395
  153. Rossi HH, Zaider M. Microdosimetry and its Applications. Berlin, Germany: Springer; 1996;
  154. Roth J, Brown N, Catterall M, et al.  Effects of fast neutrons on the eye. Br. J. Ophthalmol. 1976;60:236–278
  155. Sacher GA. Dose, dose rate radiation quality and host factors for radiation-induced life shortening. In:  Smith K editors. Aging, Carcinogenesis and Radiation Biology. New York, USA: Raven Press; 1976;p. 493–517
  156. Sasaki MS, Kobayashi K, Hieda K, et al.  Induction of chromosome aberrations in human lymphocytes by monochromatic x rays of quantum energy between 4.8 and 14.6 keV. Int. J. Radiat. Biol. 1989;56:975–988
  157. Sasaki MS. Primary damage and fixation of chromosomal DNA as probed by monochromatic soft x rays and low-energy neutrons. In:  Fielden EM,  O'Neil P editor. The Early Effects of Radiation on DNA. NATO ASI Series, Vol. H54. Berlin, Germany: Springer-Verlag; 1991;p. 369–384
  158. Sax K. Chromosome aberrations induced by x rays. Genetics. 1938;23:494–516
  159. Schmid E, Schraube H, Bauchinger M. Chromosome aberration frequencies in human lymphocytes irradiated in a phantom by a mixed beam of fission neutrons and gamma-rays. Int. J. Radiat. Biol. 1998;73:263–267
  160. Schmid E, Regulla D, Guldbakke S, et al.  The effectiveness of monoenergetic neutrons at 565 keV in producing dicentric chromosomes in human lymphocytes at low doses. Radiat. Res. 2000;154:307–312
  161. Schmid E, Regulla D, Guldbakke S, et al.  Relative biological effectiveness of 144 keV neutrons in producing dicentric chromosomes in human lymphocytes compared with 60Co gamma rays under head-to-head conditions. Radiat. Res. 2002;157:453–460
  162. Schmid E, Regulla D, Kramer HM, et al.  The effect of 29 kV x rays on the dose response of chromosome aberrations in human lymphocytes. Radiat. Res. 2002;158:771–777
  163. Schmid E. Is there reliable experimental evidence for a low-dose RBE of about 4 for mammography x rays relative to 200 kV x rays?. Radiat. Res. 2002;158:778–781
  164. Schmid, E., Schlegel, D., Guldbakke, S., et al. (2003) The RBE of nearly mono-energetic neutrons at energies from 36 keV to 14.6 MeV for inducing dicentrics in human lymphocytes. Radiat. Envir. Bioph., in press.
  165. Shellabarger, C., Kellerer, A.M., Rossi, H.H., et al. (1974) Rat mammary carcinogenesis following neutron or x-irradiation. In: Biological Effects of Neutron Irradiation. IAEA, Vienna, Austria.
  166. Shellabarger CJ, Chmelevsky D, Kellerer AM. Induction of mammary neoplasms in the Sprague-Dawley rat by 430-keV neutrons and x rays. J. Natl. Cancer Inst. 1980;64:821–832
  167. Shellabarger CJ, Chmelevsky D, Kellerer AM, et al.  Induction of mammary neoplasms in the AC1 rat by 430 keV neutrons and x rays and diethylstilbestrol. J. Natl. Cancer Inst. 1982;69:1135–1146
  168. Shimizu Y, Kato H, Schull WJ, et al.  Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 3. Noncancer mortality based on the revised doses (DS86). Radiat. Res. 1992;130:249–266
  169. Shimuzu Y, Pierce DA, Preston DL, et al.  Studies of the mortality of atomic bomb survivors. Report 12, Part II. Noncancer mortality: 1950–1990. Radiat. Res. 1999;152:374–389
  170. Shore RE, Worgul BV. Overview of the epidemiology of radiation carcinogenesis. In:  Junk AK,  Kundiev Y,  Vitte P, et al. editor. Ocular Risk Assessment in Populations Exposed to Environmental Radiation Contamination. Dordrecht, The Netherlands: Kluwer Academic Publishers; 1999;p. 183–189
  171. Sinclair WK. Fifty years of neutrons in biology and medicine; the comparative effects of neutrons in biological systems. In:  Booz J,  Ebert HA editor. Proceedings of the 8th Symposium on Microdosimetry. Luxembourg: European Communities; 1982;
  172. Sinclair WK. Experimental RBE values of high LET radiations at low doses and the implications for quality factor assignment. Radiat. Prot. Dosim. 1985;13:319–326
  173. Sinclair WK. Quality Factor, concepts and issues. Radiat. Prot. Dosim. 1990;31:355–359
  174. Sinclair WK. The present system of quantities and units for radiation protection. Health Phys. 1996;70:781–786
  175. Skarsgard LD. Radiobiology with heavy charged particles (a historical review). Phys. Med. 1998;14(Suppl.):1–19
  176. Sparrow AH, Underbrink AG, Rossi HH. Mutations induced in Tradescantia by small doses of x rays and neutrons (analysis of dose-response curves). Science. 1972;176:916–918
  177. Spiers FW, Lucas HF, Rundo J, et al.  Leukaemia incidence in the U.S. dial workers. Health Phys. 1983;44(Suppl.):65–72
  178. Stehney AH. Health studies of U.S. women radium dial workers. In:  Young JP,  Yalow RS editor. Radiation and Public Perception: Benefits and Risks. Washington, USA: American Chemical Society; 1995;
  179. Storer JB, Mitchell TJ. Limiting values for RBE of fission neutrons at low doses for life shortening in mice. Radiat. Res. 1984;97:396–406
  180. Storer JB, Fry RJM. On the shapes of the neutron dose-effect curves for radiogenic cancer and life shortening in mice. Radiat. Environ. Biophys. 1995;34:21–27
  181. Straume T. Risk implications of the neutron discrepancy in the Hiroshima DS86 dosimetry system. Radiat. Prot. Dosim. 1996;67:9–12
  182. Takatsuji T, Sasaki MS. Dose-effect relationship of chromosome aberrations induced by 23 MeV alpha particles in human lymphocytes. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 1984;45:237–243
  183. Taucher-Scholz G, Kraft G. Influence of radiation quality on the yield of DNA strand breaks for SV40 DNA irradiated in solution. Radiat. Research. 1999;151:595–604
  184. Taylor GN, Mays CW, Lloyd RD, et al.  Comparitive toxicity of 226Ra, 230Pu, 249Cf and 252 in C57 BI/Do and albino mice. Radiat. Res. 1983;95:584–601
  185. Taylor L. The Tripartite Conference on Radiation Protection: Canada, United Kingdom and United States (1949-53). US Department of Energy, Publication NVO-271 (DE 84016028). Washington, USA: US Department of Energy; 1984;
  186. Terzaghi M, Ford J. Effects of radiation on rat respiratory cells (critical target cell populations and the importance of cell-cell interactions). Adv. Space Res. 1994;14:565–572
  187. Testard J, Ricoul M, Hoffschir F, et al.  Radiation-induced chromosome damage in astronauts’ lymphocytes. Int. J. Radiat. Biol. 1996;70:403–411
  188. Testard I, Dutrillaux B, Sabatier L. Chromosomal aberrations induced in human lymphocytes by high-LET irradiation. Int. J. Radiat. Biol. 1997;72:423–433
  189. Thomas RH, Lindell B. In radiological protection, the protection quantities should be expressed in terms of measurable physical quantities. Radiat. Prot. Dosim. 2001;94:287–292
  190. Thomas RH. The impact of ICRP/ICRU quantities on high energy neutron dosimetry (a review). Radiat. Prot. Dosim. 2001;96:407–422
  191. Thomas RH, McDonald JC, Goldfinch EP. The ICRP and dosimetry (Glasnost Redux). Radiat. Prot. Dosim. 2002;102:195–200
  192. Thomson JF, Williamson FS, Grahn D. Life shortening in mice exposed to fission neutrons and gamma rays. III. neutron exposures of 5 and 10 rad. Radiat. Res. 1983;93:205–209
  193. Thomson JF, Williamson FS, Grahn D. Life shortening in mice exposed to fission neutrons and γ rays. V. Further studies with single low doses. Radiat. Res. 1985;104:420–428
  194. Tobias CA, Grigoryev YG. Ionizing radiation. In:  Calvin M,  Gazenko OG editor. Foundations of Space Biology and Medicine, Vol. 2. Washington, USA: National Aeronautics and Space Administration, Scientific and Technical Information Office; 1975;p. 473–530
  195. Ullrich RL, Jernigan MC, Cosgrove GE, et al.  The influence of dose and dose rate on the incidence of neoplastic disease in RFM mice after neutron radiation. Radiat. Res. 1976;68:115–131
  196. Ullrich RL, Jernigan MC, Storer JB. Neutron carcinogenesis. Dose and dose-rate effects in BALB/c mice. Radiat. Res. 1977;72:487–498
  197. Ullrich RL. Tumor induction in BALB/c female mice after fission neutrons or gamma irradiation. Radiat. Res. 1983;93:506–515
  198. Ullrich RL. Tumor induction in BALB/c mice after fractionated or protracted exposures to fission spectrum neutrons. Radiat. Res. 1984;97:587–597
  199. Ullrich RL, Preston RJ. Myeloid leukaemia in male RFM mice following irradiation with fission spectrum neutrons or gamma rays. Radiat. Res. 1987;109:165–170
  200. UNSCEAR . Ionizing Radiation: Sources and Biological Effects. 1982 Report to the General Assembly, with Annexes. New York, USA: United Nations Scientific Committee on the Effects of Atomic Radiation. United Nations; 1982;
  201. UNSCEAR . Sources, Effects and Risks of lonizing Radiation, 1988 Report to the General Assembly, with Annexes. New York, USA: United Nations Scientific Committee on the Effects of Atomic Radiation. United Nations; 1988;
  202. UNSCEAR . Sources and Effects of lonizing Radiation, 1993 Report to the General Assembly, with Annexes. New York, USA: United Nations Scientific Committee on the Effects of Atomic Radiation. United Nations; 1993;
  203. UNSCEAR . Sources and Effects of Ionizing Radiation, Vol. 2, Annex I: Epidemiological Evaluation of Radiation-induced Cancer. New York, USA: United Nations Scientific Committee on the Effects of Atomic Radiation. United Nations; 2000;
  204. Upton AC, Randolph ML, Conklin JW, et al.  Late effects of fast neutrons and gamma-rays in mice as influenced by the dose rate of irradiation (induction of neoplasia). Radiat. Res. 1970;41:467–491
  205. Urano M, Verhey LJ, Goitein M, et al.  Relative biological effectiveness of modulated proton beams in various murine tissues. Int. J. Radiat. Oncol. Biol. Phys. 1984;10:509–514
  206. van Kaick G, Dalheimer A, Hornik S, et al.  The German thorotrast study (recent results and assessment of risks). Radiat. Res. 1999;152(Suppl.):S64–S71
  207. Wolf C, Lafuma J, Masse R, et al.  Neutron RBE for tumors with high lethality in Sprague-Dawley rats. Radiat. Res. 2000;154:412–420
  208. Wood DH. Long-term mortality and cancer risk in irradiated Rhesus monkeys. Radiat. Res. 1991;126:132–140
  209. Worgul BV, Medvedovsky C, Huang Y, et al.  Quantitative assessment of the cataractogenic potential of very low doses of neutrons. Radiat. Res. 1996;145:343–349
  210. Wouters BG, Skarsgard LD. Low-dose radiation sensitivity and induced radioresistance to cell killing in HT-29 cells is distinct from the “adaptive response” and cannot be explained by a subpopulation of sensitive cells. Radiat. Res. 1997;148:435–442
  211. Yang TC, Craise LM, Mei MT, et al.  Neoplastic cell transformation by heavy-charged particles. Radiat. Res. 1985;104(Suppl.):S177–S187
  212. Yang TC, Mei M, George KA, et al.  DNA damage and repair in oncogenic transformation by heavy ion radiation. Adv. Space Res. 1996;18:149–158
  213. Zaider M, Brenner DJ. On the microdosimetric definition of quality factors. Radiat. Res. 1985;103:302–306
  214. Zirkle RE, Marchbank DF, Kuck KD. Exponential and sigmoid survival curves resulting from alpha and X-irradiation of Aspergillus spores. J. Cellular Comp. Physiol. 1952;39(Suppl.):75–85

PII: S0146-6453(03)00024-1

doi: 10.1016/S0146-6453(03)00024-1

Annals of the ICRP
Volume 33, Issue 4 , Pages 1-121 , December 2003

Article Tools

* Image Usage & Resolution